CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 258 enrolled
Drug / intervention
Hummingbird Tympanostomy Tube System (H-TTS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03544138
NCT03544138N/ACompleted

Pivotal Study of the Preceptis Medical Inc. Hummingbird™ Tympanostomy Tube System (H-TTS) in the Otolaryngology Clinic

Preceptis Medical, Inc.·interventional·Posted Jun 1, 2018·Updated Dec 14, 2022

In Brief

A clinical study evaluating Hummingbird Tympanostomy Tube System (H-TTS) for Ear Infection and Otitis Media. Completed, enrolled 258 participants across 7 sites.

Detailed Summary

The objective of this study is to evaluate the safety and performance of the Hummingbird® for the placement of ear tubes in children undergoing tympanostomy tube placement in an otolaryngology clinic using local anesthetic.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 1, 2018
Enrollment StartJul 24, 2018
Primary CompletionSep 6, 2022
Study CompletionSep 12, 2022
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 8.1 years ago

Interventions

Hummingbird Tympanostomy Tube System (H-TTS)device

The H-TTS is intended to deliver a tympanostomy tube through the tympanic membrane of a patient during a tympanostomy procedure.